← Surfer · Coach hub

Coach — GI: Holobiont Symbiosis & Autoimmune Gastritis

Bloating, talk of a "leaky gut," stubborn low ferritin, autoimmune gastritis, and shelves of probiotics are usually treated as separate gut stories. The working hypothesis here reads them as one story about a partnership: mitochondria inside our cells and microbes in our gut, two nested bacterial alliances that together power the body. When that partnership frays, barrier failure, inflammation, autoimmunity, and iron problems appear downstream.

Safety before ideas

This essay does not replace gastroenterology. The extended report opens with its cautions: "GI bleeding, perforation, obstruction, severe dehydration, acute abdomen, progressive dysphagia, unexplained weight loss with alarm features, and suspected neuroendocrine or gastric malignancy clocks belong in urgent clinical care. Do not stop PPIs, H. pylori regimens, iron/B12 replacement, or immunosuppressants from this page." It also limits its own promises: "Hypothesis language is not a promise that gastritis, dysbiosis, IBD, or ferritin will reverse."

A few practical cautions follow. A microbiome diversity score or a single probiotic brand is not proof that anything has been repaired. A diet of mostly raw vegetables is not automatically anti-inflammatory, especially when stomach acid is low. Exotic probiotic stacks are not a first step ahead of food. No peptide, hormone, or GLP-1 gut protocol is offered here, and no dosing. If the question is whether to stop iron infusions, B12 injections, or an acid-suppressing drug, that decision belongs with the physician who knows the case.

Two nested partnerships

The report begins with evolution. The eukaryotic cell itself arose from symbiosis: current evidence points to an ancient merger of a host from the Asgard archaea lineage with a bacterium that became the mitochondrion, supplying efficient oxidative phosphorylation in return for a protected home. The gut community extends that pattern outward, as an external metabolic organ. Humans encode roughly 20,000 protein-coding genes; the gut microbiome collectively encodes an estimated 3 to 10 million.

Those microbial genes do work the human genome cannot. They unlock plant fibers and resistant starches and turn them into short-chain fatty acids. Some species make B vitamins and vitamin K2. They transform bile acids into signals that regulate liver metabolism and gut hormones. They turn tryptophan into compounds that strengthen the gut barrier and tune immunity. And they make butyrate, which serves as fuel, as a signal, and as an epigenetic regulator. Keystone species such as Faecalibacterium prausnitzii, Roseburia, Eubacterium rectale, and Akkermansia muciniphila carry outsized influence. Problem species are context-dependent: normally kept in check, harmful when ecological checks fail. That is why, in the report's view, simple good-bug and bad-bug lists help little, and restoring diversity and keystone function often matters more than eliminating any single organism.

Colon cells that run on butyrate

The clearest dependence is in the colon. Colon cells get roughly 60 to 70 percent of their ATP from burning butyrate and other short-chain fatty acids in their mitochondria. Butyrate also keeps the base of the colon's crypts low in oxygen, which favors stem-cell quiet and limits problem species; tightens the junctions between cells; stimulates mucus; induces antimicrobial peptides; and promotes regulatory T cells that teach tolerance.

When butyrate production falls, through low fiber diversity, loss of keystone producers, or antibiotics, colon cells shift toward glycolysis. Junctions loosen, mucus thins, and bacterial products such as LPS cross the barrier. The result is metabolic endotoxemia: immune receptors fire, inflammatory signals rise, and low-grade inflammation spreads through the body. Inflammation further damages mitochondria and favors problem species, which deepens the deficit. In the report's account, this feed-forward loop helps explain why inflammatory bowel disease, metabolic syndrome, and aspects of depression and neurodegeneration often occur together. The deeper treatment is in the report's section on colon cell energetics and the barrier, and the same partnership read as a cancer field appears in the cancer report's colon section and the cancer essay.

A ratchet of loss

The report describes modern life as a ratchet. Diets have lost much of their complex-carbohydrate diversity and resistant starch. Repeated or early-life antibiotics and acid-suppressing drugs act as pulses of disruption. Urban living, cesarean delivery, formula feeding, and less contact with soil, animals, and ferments reduce the microbes we are exposed to. The functions that disappear are encoded in species that have been displaced, not merely reduced, which is why probiotics alone often fail to reverse established dysbiosis. Ultra-processed foods add emulsifiers that thin mucus and non-nutritive sweeteners that can alter the community. Antibiotics remain lifesaving in acute infection; the report also calls them "pulsed mass-extinction events" for the gut.

For repair, the report favors traditionally fermented foods as the best supply of microbiota-accessible carbohydrates: unpasteurized sauerkraut, kimchi, real pickles, fermented onions and beets. Lactic fermentation consumes simple sugars, reduces many plant anti-nutrients, and is easier to digest, which in the report's view makes these foods compatible with lower-carbohydrate eating. It frames this as "hypothesis language, not a branded diet order."

The useful measures sit beside the gut tests rather than replacing them: grip, strength, fitness, lean mass, recovery, sleep timing, daylight, and how much ultra-processed food is eaten. The gut readings stay with the physicians who order them, including ferritin with a fuller iron panel, B12, antibodies to intrinsic factor and parietal cells when autoimmune gastritis is in question, gastrin and pepsinogen where used, H. pylori testing, and fecal calprotectin or endoscopy when inflammatory bowel disease or alarm features call for them. Research measures such as fecal butyrate or functional metagenomics are useful only where available and justified; no home test reveals a "gut type."

Raw plants and the full nutrient matrix

A diet built mostly on raw vegetables is often promoted as anti-inflammatory. The report names its limits when stomach acid is low and the gut is already strained. Heme iron, preformed B12, and complete amino-acid profiles are absent or poorly absorbed from plants, which matters more when acid and intrinsic factor are lacking. Many plant compounds, such as oxalates, lectins, phytates, and goitrogens, are reduced by cooking or fermentation, and large amounts of unprocessed plant material can add to the burden of a compromised gut. Cell membranes need particular fats and cholesterol, and strict exclusion of animal fats removes a ready supply. The report is clear that "None of this argues for the absence of plants." Its point is that context, absorption, and the full nutrient matrix matter more than purity.

The pillars follow from that. Fuel means animal proteins and fats for the host's own mitochondria, diverse traditionally fermented foods for the butyrate-making community, and fewer industrial seed oils and ultra-processed additives, as described in the fuel essay. Circadian care means morning outdoor light, consistent sleep, and meal windows; the report says time-restricted eating or intermittent fasting may help "where medically appropriate," and not for every candidate. Strength means progressive resistance training, which improves insulin sensitivity and creates conditions in which a diverse community can re-establish itself. When antibiotics are needed, they are used; prompt reintroduction of good ferments afterward is, in the report's words, something that "deserves systematic study as restoration strategy". Early-life seeding through vaginal birth when safe, skin-to-skin contact, and breastfeeding is described as public-health language, "not a rebuke of necessary obstetric care."

Autoimmune gastritis and the ferritin sentinel

Autoimmune gastritis is usually told as immune cells attacking the stomach's acid pump. The report reads it as more than that. Parietal cells, which make stomach acid with the H+/K+-ATPase pump, do some of the most energy-intensive work in the body. In this hypothesis, a mitochondrial shortfall in those cells may expose the pump to the immune system, so that the attack follows an energy failure as much as it starts one. Loss of acid then sets off a cascade of poor iron and B12 absorption. Ferritin, in this reading, is a redox and energy sentinel, not only a measure of iron stores. Genetic risk and H. pylori mimicry operate on the same metabolic ground.

The counseling tone matters here. Two cartoons are worth avoiding: that autoimmune gastritis is only antibodies, and that it means mitochondria are irrelevant. The destruction of parietal cells and the loss of intrinsic factor are real, and so is the need to monitor for stomach tumors and to replace what cannot be absorbed. The report states that "Iron and B12 replacement remain necessary when absorption is broken — often parenteral first — guided by fuller panels than ferritin alone." Food, fermented foods, and redox balance still matter as the ground on which autoimmunity expresses itself. None of this claims that diet cures antibody levels or restores parietal cells on a schedule. The full essay is the metabolic hypothesis of autoimmune gastritis, with a companion on ferritin.

Order of questions

The sequence is plain. First come acute and specialty problems: bleeding, obstruction, alarm features, H. pylori care according to guidelines, surveillance in autoimmune gastritis, and inflammatory bowel disease flares. Then the everyday ground of fermented foods and animal nutrients, light, sleep, and strength, as gathered on the common-ground page. Then capacity is tracked beside whatever gut tests the physician already runs. The route of iron and B12, acid-suppressing drugs, antibiotics, and immune-suppressing drugs stay with the treating physician, and the first question about a lifelong oral megadose is why absorption failed.

Several errors are worth naming. One buys probiotics without changing the food. Another follows raw-plant ideology in a person whose stomach no longer makes acid. A third chases ferritin with oral iron without asking about acid, inflammation, and sequestration. The opposite error rejects indicated infusions, injections, or H. pylori treatment out of ideology. A gut that is struggling is never a moral failing.

Limits and related topics

This is a working hypothesis. The report states that it is "Not a randomized-trial verdict that fermented-MAC / mitochondrial-first strategies outperform guideline gastroenterology, iron/B12 replacement, H. pylori care, or IBD specialty protocols as monotherapy." It "Does not deny true autoimmune destruction, H. pylori disease, celiac clocks, IBD as entities, gastric malignancy surveillance, or the clinical utility of acid suppression and parenteral replacement when indicated." The report also offers falsifiable predictions: populations that eat more good ferments, less ultra-processed food, and take fewer unnecessary antibiotics should show more fecal butyrate, better barrier markers, better insulin sensitivity and hunger regulation, and less of the cluster of conditions now labeled as separate diseases.

The autoimmune gastritis section above carries the counseling core. Related reports cover autoimmune gastritis, colon cell energetics, the colon, mitochondria, and microbiome axis, and ferritin. For the full argument, read the extended report on the gut. The short version is in the lessons. Talk with your own physician before changing medications or supplements.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 17, 2026.